Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$4.11 -0.38 (-8.46%)
As of: Nov 10, 2026 · 3:22 PM EST

Tonix Pharmaceuticals Holding (TNXP) Work In Process (2023 - 2025)

Updated

Tonix Pharmaceuticals Holding (TNXP) reported Work In Process of $1.37 million for Q4 2025, up 543.2% from $213,000 a year earlier but down 7.8% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Work In Process (2023 - 2025) Analysis & Trends

Dating back to Q4 2023, Tonix Pharmaceuticals Holding's Work In Process record includes 7 quarters.

  • By year, Work In Process came in at $213,000 in FY2024 (-91.6%) and $2.54 million in FY2023.
  • Five-year quarterly Work In Process spans a low of $213,000 in Q4 2024 and a high of $2.54 million in Q4 2023.
  • Per Business Quant data, the three quarters before Q4 2025 came in at $1.49 million (Q3 2025), $1.27 million (Q2 2025) and $664,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tonix Pharmaceuticals Holding 74.61 Mn -684.78 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.37 Mn
Sep 30, 2025 1.49 Mn
Jun 30, 2025 1.27 Mn
Mar 31, 2025 664,000.00
Dec 31, 2024 213,000.00
Sep 30, 2024 1.95 Mn
Dec 31, 2023 2.54 Mn
API Access

Tonix Pharmaceuticals Holding Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=TNXP&period=max&api_key=YOUR_API_KEY